{
    "title": "Heart safety clouds hopes for Amgen, UCB bone drug approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4528524/Higher-rate-heart-problems-Amgen-osteoporosis-drug-trial.html",
    "date": "2017-05-21",
    "keywords": [
        "drug",
        "romosozumab",
        "percent",
        "approval",
        "amgen",
        "side",
        "trial",
        "evenity",
        "study",
        "bill",
        "berkrot",
        "hirschler",
        "osteoporosis",
        "latestage",
        "decision",
        "safety",
        "problem",
        "growth",
        "competition",
        "time",
        "analyst",
        "raffat",
        "research",
        "risk",
        "inc",
        "sa",
        "year",
        "rate",
        "brand",
        "name",
        "food",
        "administration",
        "consideration",
        "agency",
        "ruling",
        "july",
        "news",
        "blow",
        "setback",
        "hard",
        "monday",
        "afternoon",
        "uncertainty",
        "radius",
        "health",
        "april",
        "nature",
        "severity",
        "geoffrey",
        "probability",
        "market",
        "note",
        "forecast",
        "future",
        "driver",
        "thomson",
        "statement",
        "efficacy",
        "control",
        "signal",
        "part",
        "benefitrisk",
        "profile",
        "harper",
        "field",
        "evaluation",
        "injection",
        "canada",
        "japan",
        "bone",
        "formation",
        "density",
        "medicine",
        "imbalance",
        "phase",
        "iii",
        "basis",
        "submission",
        "incidence",
        "fracture",
        "merck",
        "amp",
        "cos",
        "heart",
        "versus",
        "fosomax",
        "group",
        "reporting",
        "york",
        "editing",
        "louise",
        "matthew",
        "lewis"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}